Pharvaris
Aimee Sundberg serves as the Executive Director and Clinical Development Lead at Pharvaris, bringing significant expertise in clinical development. Previously, Aimee worked at Shire as a Clinical Development Scientist specializing in Transplant Medicine. Aimee also held the position of Associate Director and Medical Science Liaison in Transplant at Novartis, showcasing a strong background in the field of transplant medicine and clinical research.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.